{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T23:58:12Z","timestamp":1790639892003,"version":"4.1.0"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-026-04759-5","type":"journal-article","created":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T06:32:28Z","timestamp":1790577148000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Newborn screening for congenital adrenal hyperplasia: a 3 years study embedded in 25 years of regional experience in Italy"],"prefix":"10.1007","volume":"91","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5862-8958","authenticated-orcid":false,"given":"Gerdi","family":"Tuli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-2436-3511","authenticated-orcid":false,"given":"Jessica","family":"Munarin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5499-1354","authenticated-orcid":false,"given":"Enza","family":"Pavanello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2113-6196","authenticated-orcid":false,"given":"Luisa","family":"De Sanctis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,28]]},"reference":[{"key":"4759_CR1","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1210\/endrev\/bnab016","volume":"43","author":"HL Claahsen-van der Grinten","year":"2022","unstructured":"H.L. Claahsen-van der Grinten, P.W. Speiser, S.F. Ahmed, W. Arlt, R.J. Auchus, H. Falhammar, C.E. Fl\u00fcck, L. Guasti, A. Huebner, B.B.M. Kortmann et al. Congenital Adrenal Hyperplasia-Current Insights in Pathophysiology, Diagnostics, and Management. Endocr. Rev. 43, 91\u2013159 (2022)","journal-title":"Endocr. Rev."},{"key":"4759_CR2","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/S0140-6736(22)01330-7","volume":"401","author":"MK Auer","year":"2023","unstructured":"M.K. Auer, A. Nordenstr\u00f6m, S. Lajic, N. Reisch, Congenital adrenal hyperplasia. Lancet. 401, 227\u2013244 (2023)","journal-title":"Lancet"},{"key":"4759_CR3","doi-asserted-by":"publisher","first-page":"4043","DOI":"10.1210\/jc.2018-01865","volume":"103","author":"PW Speiser","year":"2018","unstructured":"P.W. Speiser, W. Arlt, R.J. Auchus, L.S. Baskin, G.S. Conway, D.P. Merke, H.F.L. Meyer-Bahlburg, W.L. Miller, M.H. Murad, S.E. Oberfield et al. Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society Clinical Practice Guideline. J. Clin. Endocrinol. Metab. 103, 4043\u20134088 (2018)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4759_CR4","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/s41574-022-00655-w","volume":"18","author":"A Mallappa","year":"2022","unstructured":"A. Mallappa, D.P. Merke, Management challenges and therapeutic advances in congenital adrenal hyperplasia. Nat. Rev. Endocrinol. 18, 337\u2013352 (2022)","journal-title":"Nat. Rev. Endocrinol."},{"key":"4759_CR5","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1542\/peds.98.3.362","volume":"98","author":"A Balsamo","year":"1996","unstructured":"A. Balsamo, E. Cacciari, S. Piazzi, A. Cassio, D. Bozza, P. Pirazzoli, F. Zappulla, Congenital adrenal hyperplasia: neonatal mass screening compared with clinical diagnosis only in the Emilia-Romagna region of Italy, 1980\u20131995. Pediatrics. 98, 362\u2013367 (1996)","journal-title":"Pediatrics"},{"key":"4759_CR6","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1001\/archpedi.153.12.1272","volume":"153","author":"PG Brosnan","year":"1999","unstructured":"P.G. Brosnan, C.A. Brosnan, S.F. Kemp, D.B. Domek, D.H. Jelley, P.R. Blackett, W.J. Riley, Effect of Newborn Screening for Congenital Adrenal Hyperplasia. Arch. Pediatr. Adolesc. Med. 153, 1272 (1999)","journal-title":"Arch. Pediatr. Adolesc. Med."},{"key":"4759_CR7","doi-asserted-by":"crossref","unstructured":"B.L. Jr Therrell, S.A. Berenbaum, V. Manter-Kapanke, J. Simmank, K. Korman, L. Prentice, J. Gonzalez, S. Gunn, (1998) Results of Screening 1.9 Million Texas Newborns for 21-Hydroxylase-Deficient Congenital Adrenal Hyperplasia. Pediatrics. 101, 583\u2013590 (1998)","DOI":"10.1542\/peds.101.4.583"},{"key":"4759_CR8","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.1542\/peds.101.4.e11","volume":"101","author":"A Thil\u2019","year":"1998","unstructured":"A. Thil\u2019, A. Nordenstr\u00f6m, L. Hagenfeldt, von U. D\u00f6beln, C. Guthenberg, A. Larsson, Benefits of Neonatal Screening for Congenital Adrenal Hyperplasia (21-Hydroxylase Deficiency) in Sweden. Pediatrics. 101, e11\u2013e11 (1998)","journal-title":"Pediatrics"},{"issue":"Suppl 1","key":"4759_CR9","first-page":"1S","volume":"8","author":"Newborn screening","year":"2006","unstructured":"Newborn screening, toward a uniform screening panel and system. Genet. Med. 8(Suppl 1), 1S\u2013252S (2006)","journal-title":"Genet. Med."},{"key":"4759_CR10","first-page":"284","volume":"67","author":"SD Grosse","year":"2007","unstructured":"S.D. Grosse, Van G. Vliet, How Many Deaths Can Be Prevented by Newborn Screening for Congenital Adrenal Hyperplasia? Horm. Res. Paediatr. 67, 284\u2013291 (2007)","journal-title":"Res. Paediatr."},{"key":"4759_CR11","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1136\/archdischild-2013-304473","volume":"99","author":"BE Hird","year":"2014","unstructured":"B.E. Hird, L. Tetlow, S. Tobi, L. Patel, P.E. Clayton, No evidence of an increase in early infant mortality from congenital adrenal hyperplasia in the absence of screening. Arch. Dis. Child. 99, 158\u2013164 (2014)","journal-title":"Arch. Dis. Child."},{"key":"4759_CR12","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1542\/peds.108.6.1320","volume":"108","author":"HJ Van der Kamp","year":"2001","unstructured":"Van der H.J. Kamp, K. Noordam, B. Elvers, Van M. Baarle, B.J. Otten, P.H. Verkerk, Newborn screening for congenital adrenal hyperplasia in the Netherlands. Pediatrics. 108, 1320\u20131324 (2001)","journal-title":"Pediatrics"},{"key":"4759_CR13","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1097\/00008480-199708000-00018","volume":"9","author":"S Pang","year":"1997","unstructured":"S. Pang, M.K. Shook, Current status of neonatal screening for congenital adrenal hyperplasia. Curr. Opin. Pediatr. 9, 419\u2013423 (1997)","journal-title":"Curr. Opin. Pediatr."},{"key":"4759_CR14","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.jpeds.2005.04.035","volume":"147","author":"TS Varness","year":"2005","unstructured":"T.S. Varness, D.B. Allen, G.L. Hoffman, Newborn screening for congenital adrenal hyperplasia has reduced sensitivity in girls. J. Pediatr. 147, 493\u2013498 (2005)","journal-title":"J. Pediatr."},{"key":"4759_CR15","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.jpeds.2013.01.002","volume":"163","author":"CL Chan","year":"2013","unstructured":"C.L. Chan, K. McFann, L. Taylor, D. Wright, P.S. Zeitler, J.M. Barker, Congenital adrenal hyperplasia and the second newborn screen. J. Pediatr. 163, 109\u2013113 (2013)","journal-title":"J. Pediatr."},{"key":"4759_CR16","doi-asserted-by":"publisher","first-page":"e1261","DOI":"10.1542\/peds.2012-1219","volume":"130","author":"K Sarafoglou","year":"2012","unstructured":"K. Sarafoglou, K. Banks, A. Gaviglio, A. Hietala, M. McCann, W. Thomas, Comparison of one-tier and two-tier newborn screening metrics for congenital adrenal hyperplasia. Pediatrics. 130, e1261\u20131268 (2012)","journal-title":"Pediatrics"},{"key":"4759_CR17","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1016\/j.jpeds.2014.01.038","volume":"164","author":"K Sarafoglou","year":"2014","unstructured":"K. Sarafoglou, A. Gaviglio, A. Hietala, G. Frogner, K. Banks, M. McCann, W. Thomas, Comparison of newborn screening protocols for congenital adrenal hyperplasia in preterm infants. J. Pediatr. 164, 1136\u20131140 (2014)","journal-title":"J. Pediatr."},{"key":"4759_CR18","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.ymgme.2015.08.004","volume":"116","author":"PK Held","year":"2015","unstructured":"P.K. Held, S.K. Shapira, C.F. Hinton, E. Jones, W.H. Hannon, J. Ojodu, Congenital adrenal hyperplasia cases identified by newborn screening in one- and two-screen states. Mol. Genet. Metab. 116, 133\u2013138 (2015)","journal-title":"Mol. Genet. Metab."},{"key":"4759_CR19","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1038\/nrendo.2009.148","volume":"5","author":"PC White","year":"2009","unstructured":"P.C. White, Neonatal screening for congenital adrenal hyperplasia. Nat. Rev. Endocrinol. 5, 490\u2013498 (2009)","journal-title":"Nat. Rev. Endocrinol."},{"key":"4759_CR20","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.cca.2014.07.036","volume":"438","author":"JA Ray","year":"2015","unstructured":"J.A. Ray, M.M. Kushnir, R.A. Yost, A.L. Rockwood, A. Wayne Meikle, Performance enhancement in the measurement of 5 endogenous steroids by LC\u2013MS\/MS combined with differential ion mobility spectrometry. Clin. Chim. Acta. 438, 330\u2013336 (2015)","journal-title":"Clin. Chim. Acta"},{"key":"4759_CR21","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1159\/000337974","volume":"77","author":"N Janzen","year":"2012","unstructured":"N. Janzen, F.G. Riepe, M. Peter, S. Sander, U. Steuerwald, E. Korsch, F. Krull, H.L. M\u00fcller, S. Heger, C. Brack et al. Neonatal screening: identification of children with 11\u03b2-hydroxylase deficiency by second-tier testing. Horm. Res. Paediatr. 77, 195\u2013199 (2012)","journal-title":"Horm. Res. Paediatr."},{"key":"4759_CR22","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/BF03262053","volume":"6","author":"Y Yang","year":"2001","unstructured":"Y. Yang, Reverse dot-blot hybridization as an improved tool for the molecular diagnosis of point mutations in congenital adrenal hyperplasia caused by 21-hydroxylase deficiency. Mol. Diagnosis. 6, 193\u2013199 (2001)","journal-title":"Mol. Diagnosis"},{"key":"4759_CR23","first-page":"960","volume":"84","author":"J Fitness","year":"1999","unstructured":"J. Fitness, N. Dixit, D. Webster, T. Torresani, R. Pergolizzi, P.W. Speiser, D.J. Day, Genotyping of CYP21, linked chromosome 6p markers, and a sex-specific gene in neonatal screening for congenital adrenal hyperplasia. J. Clin. Endocrinol. Metab. 84, 960\u2013966 (1999)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4759_CR24","doi-asserted-by":"publisher","first-page":"9363","DOI":"10.1021\/ac801688c","volume":"80","author":"KM S\u00f8rensen","year":"2008","unstructured":"K.M. S\u00f8rensen, P.S. Andersen, L.A. Larsen, M. Schwartz, J.P. Schouten, A.O. Nygren, Multiplex ligation-dependent probe amplification technique for copy number analysis on small amounts of DNA material. Anal. Chem. 80, 9363\u20139368 (2008)","journal-title":"Anal. Chem."},{"key":"4759_CR25","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1373\/clinchem.2004.042416","volume":"51","author":"S K\u00f6sel","year":"2005","unstructured":"S. K\u00f6sel, S. Burggraf, R. Fingerhut, H.G. D\u00f6rr, A.A. Roscher, B. Olgem\u00f6ller, Rapid second-tier molecular genetic analysis for congenital adrenal hyperplasia attributable to steroid 21-hydroxylase deficiency. Clin. Chem. 51, 298\u2013304 (2005)","journal-title":"Clin. Chem."},{"key":"4759_CR26","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1210\/jcem.87.2.8273","volume":"87","author":"RC Olney","year":"2002","unstructured":"R.C. Olney, E.B. Mougey, J. Wang, D.I. Shulman, J.E. Sylvester, Using Real-Time, Quantitative PCR for Rapid Genotyping of the Steroid 21-Hydroxylase Gene in a North Florida Population. J. Clin. Endocrinol. Metab. 87, 735\u2013741 (2002)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4759_CR27","first-page":"1505","volume":"84","author":"A Nordenstr\u00f6m","year":"1999","unstructured":"A. Nordenstr\u00f6m, A. Thil\u00e9n, L. Hagenfeldt, A. Larsson, A. Wedell, Genotyping Is a Valuable Diagnostic Complement to Neonatal Screening for Congenital Adrenal Hyperplasia due to Steroid 21-Hydroxylase Deficiency. J. Clin. Endocrinol. Metab. 84, 1505\u20131509 (1999)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4759_CR28","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1159\/000065492","volume":"58","author":"FG Riepe","year":"2022","unstructured":"F.G. Riepe, N. Krone, M. Viemann, C.J. Partsch, W.G. Sippell, Management of Congenital Adrenal Hyperplasia: Results of the ESPE Questionnaire. Horm. Res. Paediatr. 58, 196\u2013205 (2022)","journal-title":"Horm. Res. Paediatr."},{"key":"4759_CR29","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1055\/a-2022-8399","volume":"131","author":"YA Yoon","year":"2023","unstructured":"Y.A. Yoon, S. Woo, M.S. Kim, B. Kim, Y.J. Choi, Establishing 17-Hydroxyprogesterone Cutoff Values for Congenital Adrenal Hyperplasia in Preterm, Low Birth Weight, and Sick Newborns. Exp. Clin. Endocrinol. Diabetes. 131, 216\u2013221 (2023)","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"4759_CR30","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1515\/jpem-2023-0044","volume":"36","author":"K Ludwig","year":"2023","unstructured":"K. Ludwig, F. Lai, V. Wiley, A. Ravine, S. Srinivasan, Genotyping in patients with congenital adrenal hyperplasia by sequencing of newborn bloodspot samples. J. Pediatr. Endocrinol. Metab. 36, 966\u2013973 (2023)","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"4759_CR31","first-page":"271","volume":"55","author":"L Gru\u00f1eiro-Papendieck","year":"2001","unstructured":"L. Gru\u00f1eiro-Papendieck, L. Prieto, A. Chiesa, S. Bengolea, G. Bossi, C. Bergad\u00e1, Neonatal screening program for congenital adrenal hyperplasia: adjustments to the recall protocol. Horm. Res. 55, 271\u2013277 (2001)","journal-title":"Horm. Res."},{"key":"4759_CR32","doi-asserted-by":"publisher","first-page":"E68","DOI":"10.1542\/peds.108.4.e68","volume":"108","author":"A Nordenstr\u00f6m","year":"2001","unstructured":"A. Nordenstr\u00f6m, A. Wedell, L. Hagenfeldt, C. Marcus, A. Larsson, Neonatal screening for congenital adrenal hyperplasia: 17-hydroxyprogesterone levels and CYP21 genotypes in preterm infants. Pediatrics. 108, E68 (2001)","journal-title":"Pediatrics"},{"key":"4759_CR33","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1111\/cen.13292","volume":"86","author":"GY Hayashi","year":"2017","unstructured":"G.Y. Hayashi, D.F. Carvalho, de M.C. Miranda, C. Faure, C. Vallejos, V.N. Brito, A.S. Rodrigues, G. Madureira, B.B. Mendonca, T.A. Bachega, Neonatal 17-hydroxyprogesterone levels adjusted according to age at sample collection and birthweight improve the efficacy of congenital adrenal hyperplasia newborn screening. Clin. Endocrinol. (Oxf). 86, 480\u2013487 (2017)","journal-title":"Clin. Endocrinol. (Oxf)"},{"key":"4759_CR34","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1001\/jamapediatrics.2013.5321","volume":"168","author":"S Gidl\u00f6f","year":"2014","unstructured":"S. Gidl\u00f6f, A. Wedell, C. Guthenberg, von U. D\u00f6beln, A. Nordenstr\u00f6m, Nationwide neonatal screening for congenital adrenal hyperplasia in sweden: a 26-year longitudinal prospective population-based study. JAMA Pediatr. 168, 567\u2013574 (2014)","journal-title":"JAMA Pediatr."},{"key":"4759_CR35","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3390\/ijns6020037","volume":"6","author":"PW Speiser","year":"2020","unstructured":"P.W. Speiser, R. Chawla, M. Chen, A. Diaz-Thomas, C. Finlayson, M.M. Rutter, D.E. Sandberg, K. Shimy, R. Talib, J. Cerise et al. Newborn Screening Protocols and Positive Predictive Value for Congenital Adrenal Hyperplasia Vary across the United States. Int. J. Neonatal Screen. 6, 37 (2020)","journal-title":"Int. J. Neonatal Screen."},{"key":"4759_CR36","doi-asserted-by":"publisher","first-page":"623125","DOI":"10.3389\/fgene.2020.623125","volume":"11","author":"X Wang","year":"2021","unstructured":"X. Wang, Y. Wang, D. Ma, Z. Zhang, Y. Li, P. Yang, Y. Sun, T. Jiang, Neonatal Screening and Genotype-Phenotype Correlation of 21-Hydroxylase Deficiency in the Chinese Population. Front. Genet. 11, 623125 (2021)","journal-title":"Front. Genet."},{"key":"4759_CR37","doi-asserted-by":"publisher","first-page":"36","DOI":"10.3390\/ijns7030036","volume":"7","author":"A Tsuji-Hosokawa","year":"2021","unstructured":"A. Tsuji-Hosokawa, K. Kashimada, Thirty-Year Lessons from the Newborn Screening for Congenital Adrenal Hyperplasia (CAH) in Japan. Int. J. Neonatal Screen. 7, 36 (2021)","journal-title":"Int. J. Neonatal Screen."},{"key":"4759_CR38","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1159\/000524170","volume":"95","author":"P Cavarzere","year":"2022","unstructured":"P. Cavarzere, M. Camilot, L. Palma, S. Lauriola, R. Gaudino, M. Vincenzi, F. Antoniazzi, F. Teofoli, G. Piacentini, Twenty Years of Neonatal Screening for Congenital Adrenal Hyperplasia in North-Eastern Italy: Role of Liquid Chromatography-Tandem Mass Spectrometry as a Second-Tier Test. Horm. Res. Paediatr. 95, 255\u2013263 (2022)","journal-title":"Horm. Res. Paediatr."},{"key":"4759_CR39","doi-asserted-by":"publisher","first-page":"287","DOI":"10.4274\/jcrpe.galenos.2020.2019.0182","volume":"12","author":"T G\u00fcran","year":"2020","unstructured":"T. G\u00fcran, B. Tezel, M. \u00c7ak\u0131r, A. Ak\u0131nc\u0131, Z. Orbak, M. Keskin, B. Selver Eklio\u011flu, A. Ozon, M.N. \u00d6zbek, G. Karag\u00fczel et al. Neonatal Screening for Congenital Adrenal Hyperplasia in Turkey: Outcomes of Extended Pilot Study in 241,083 Infants. J. Clin. Res. Pediatr. Endocrinol. 12, 287\u2013294 (2020)","journal-title":"J. Clin. Res. Pediatr. Endocrinol."},{"key":"4759_CR40","doi-asserted-by":"publisher","first-page":"56","DOI":"10.3390\/ijns8040056","volume":"8","author":"MR de Hora","year":"2022","unstructured":"de M.R. Hora, N.L. Heather, D.R. Webster, B.B. Albert, P.L. Hofman, Evaluation of a New Laboratory Protocol for Newborn Screening for Congenital Adrenal Hyperplasia in New Zealand. Int. J. Neonatal Screen. 8, 56 (2022)","journal-title":"Int. J. Neonatal Screen."},{"key":"4759_CR41","doi-asserted-by":"publisher","first-page":"e3390","DOI":"10.1210\/clinem\/dgab383","volume":"106","author":"MR de Hora","year":"2021","unstructured":"de M.R. Hora, N.L. Heather, D. Webster, B.B. Albert, P.L. Hofman, Birth Weight- or Gestational Age-adjusted Second-tier LCMSMS Cutoffs Improve Newborn Screening for CAH in New Zealand. J. Clin. Endocrinol. Metab. 106, e3390\u2013e3399 (2021)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4759_CR42","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1159\/000522230","volume":"95","author":"M Lind-Holst","year":"2022","unstructured":"M. Lind-Holst, M. B\u00e6kvad-Hansen, A. Berglund, A.S. Cohen, L. Melgaard, K. Skogstrand, M. Duno, K.M. Main, D.M. Hougaard, C.H. Gravholt et al. Neonatal Screening for Congenital Adrenal Hyperplasia in Denmark: 10 Years of Experience. Horm. Res. Paediatr. 95, 35\u201342 (2022)","journal-title":"Horm. Res. Paediatr."},{"key":"4759_CR43","doi-asserted-by":"publisher","first-page":"100598","DOI":"10.1016\/j.lanepe.2023.100598","volume":"28","author":"A Berglund","year":"2023","unstructured":"A. Berglund, M.J. Ornstrup, M. Lind-Holst, M. Dun\u00f8, M. B\u00e6kvad-Hansen, A. Juul, L. Borch, N. J\u00f8rgensen, \u00c5.K. Rasmussen, M. Andersen et al. Epidemiology and diagnostic trends of congenital adrenal hyperplasia in Denmark: a retrospective, population-based study. Lancet Reg. Health Eur. 28, 100598 (2023)","journal-title":"Lancet Reg. Health Eur."},{"key":"4759_CR44","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3390\/ijns6030063","volume":"6","author":"F Lai","year":"2020","unstructured":"F. Lai, S. Srinivasan, V. Wiley, Evaluation of a Two-Tier Screening Pathway for Congenital Adrenal Hyperplasia in the New South Wales Newborn Screening Programme. Int. J. Neonatal Screen. 6, 63 (2020)","journal-title":"Int. J. Neonatal Screen."},{"key":"4759_CR45","doi-asserted-by":"publisher","first-page":"64","DOI":"10.3390\/ijns6030064","volume":"6","author":"S Edelman","year":"2020","unstructured":"S. Edelman, H. Desai, T. Pigg, C. Yusuf, J. Ojodu, Landscape of Congenital Adrenal Hyperplasia Newborn Screening in the United States. Int. J. Neonatal Screen. 6, 64 (2020)","journal-title":"Int. J. Neonatal Screen."},{"key":"4759_CR46","doi-asserted-by":"publisher","first-page":"624507","DOI":"10.3389\/fendo.2021.624507","volume":"12","author":"Z Li","year":"2021","unstructured":"Z. Li, L. Huang, C. Du, C. Zhang, M. Zhang, Y. Liang, X. Luo, Analysis of the Screening Results for Congenital Adrenal Hyperplasia Involving 7.85 Million Newborns in China: A Systematic Review and Meta-Analysis. Front. Endocrinol. (Lausanne). 12, 624507 (2021)","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"4759_CR47","doi-asserted-by":"crossref","unstructured":"K. Stroek, A. Ruiter, van der A. Linde, M. Ackermans, M.J. Bouva, H. Engel, B. Jakobs, E.A. Kemper, van den E.L.T. Akker, van M.E. Albada et al. Second-tier Testing for 21-Hydroxylase Deficiency in the Netherlands: A Newborn Screening Pilot Study. J. Clin. Endocrinol. Metab. 106, e4487-e4496 (2021)","DOI":"10.1210\/clinem\/dgab464"},{"key":"4759_CR48","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1159\/000508075","volume":"93","author":"N Eshragh","year":"2020","unstructured":"N. Eshragh, L.V. Doan, K.J. Connelly, S. Denniston, S. Willis, S.H. LaFranchi, Outcome of Newborn Screening for Congenital Adrenal Hyperplasia at Two Time Points. Horm. Res. Paediatr. 93, 128\u2013136 (2020)","journal-title":"Horm. Res. Paediatr."},{"key":"4759_CR49","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3390\/ijns6030071","volume":"6","author":"RH Zetterstr\u00f6m","year":"2020","unstructured":"R.H. Zetterstr\u00f6m, L. Karlsson, H. Falhammar, S. Lajic, A. Nordenstr\u00f6m, Update on the Swedish Newborn Screening for Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency. Int. J. Neonatal Screen. 6, 71 (2020)","journal-title":"Int. J. Neonatal Screen."},{"key":"4759_CR50","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1136\/archdischild-2018-315972","volume":"104","author":"AAA van der Linde","year":"2019","unstructured":"van der A.A.A. Linde, Y. Sch\u00f6nbeck, van der H.J. Kamp, van den E.L.T. Akker, van M.E. Albada, A. Boelen, M.J.J. Finken, S.E. Hannema, G. Hoorweg-Nijman, R.J. Odink et al. Evaluation of the Dutch neonatal screening for congenital adrenal hyperplasia. Arch. Dis. Child. 104, 653\u2013657 (2019)","journal-title":"Arch. Dis. Child."},{"key":"4759_CR51","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1210\/jc.2014-3168","volume":"100","author":"NL Heather","year":"2015","unstructured":"N.L. Heather, S.N. Seneviratne, D. Webster, J.G. Derraik, C. Jefferies, J. Carll, Y. Jiang, W.S. Cutfield, P.L. Hofman, Newborn screening for congenital adrenal hyperplasia in New Zealand, 1994\u20132013. J. Clin. Endocrinol. Metab. 100, 1002\u20131008 (2015)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4759_CR52","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1001\/archpediatrics.2011.774","volume":"166","author":"B Coulm","year":"2012","unstructured":"B. Coulm, J. Coste, V. Tardy, E. Ecosse, M. Roussey, Y. Morel, J.C. Carel, DHCSF Study Group, Efficiency of neonatal screening for congenital adrenal hyperplasia due to 21-hydroxylase deficiency in children born in mainland France between 1996 and 2003. Arch. Pediatr. Adolesc. Med. 166, 113\u2013120 (2012)","journal-title":"Arch. Pediatr. Adolesc. Med."},{"key":"4759_CR53","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1007\/s00431-011-1656-6","volume":"171","author":"F Votava","year":"2012","unstructured":"F. Votava, D. Novotna, P. Kracmar, H. Vinohradska, E. Stahlova-Hrabincova, Z. Vrzalova, D. Neumann, J. Malikova, J. Lebl, D. Matern, Lessons learned from 5 years of newborn screening for congenital adrenal hyperplasia in the Czech Republic: 17-hydroxyprogesterone, genotypes, and screening performance. Eur. J. Pediatr. 171, 935\u2013940 (2012)","journal-title":"Eur. J. Pediatr."},{"key":"4759_CR54","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1590\/S0004-27302011000800019","volume":"55","author":"G Hayashi","year":"2011","unstructured":"G. Hayashi, C. Faure, M.F. Brondi, C. Vallejos, D. Soares, E. Oliveira, V.N. Brito, B.B. Mendonca, T.A. Bachega, Weight-adjusted neonatal 17OH-progesterone cutoff levels improve the efficiency of newborn screening for congenital adrenal hyperplasia. Arq. Bras. Endocrinol. Metabol. 55, 632\u2013637 (2011)","journal-title":"Arq. Bras. Endocrinol. Metabol"},{"key":"4759_CR55","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s12887-016-0772-x","volume":"17","author":"C Kopacek","year":"2017","unstructured":"C. Kopacek, de S.M. Castro, M.J. Prado, da C.M. Silva, L.A. Beltr\u00e3o, P.M. Spritzer, Neonatal screening for congenital adrenal hyperplasia in Southern Brazil: a population based study with 108,409 infants. BMC Pediatr. 17, 22 (2017)","journal-title":"BMC Pediatr."},{"key":"4759_CR56","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1186\/s12887-015-0529-y","volume":"25","author":"A Tsuji","year":"2015","unstructured":"A. Tsuji, K. Konishi, S. Hasegawa, A. Anazawa, T. Onishi, M. Ono, T. Morio, T. Kitagawa, K. Kashimada, Newborn screening for congenital adrenal hyperplasia in Tokyo, Japan from 1989 to 2013: a retrospective population-based study. BMC Pediatr. 25, 209 (2015)","journal-title":"BMC Pediatr."},{"key":"4759_CR57","doi-asserted-by":"publisher","first-page":"bvz030","DOI":"10.1210\/jendso\/bvz030","volume":"4","author":"AD Chesover","year":"2019","unstructured":"A.D. Chesover, H. Millar, L. Sepiashvili, K. Adeli, M.R. Palmert, J. Hamilton, Screening for Nonclassic Congenital Adrenal Hyperplasia in the Era of Liquid Chromatography-Tandem Mass Spectrometry. J. Endocr. Soc. 4, bvz030 (2019)","journal-title":"J. Endocr. Soc."},{"key":"4759_CR58","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1055\/s-0035-1554639","volume":"227","author":"B Odenwald","year":"2015","unstructured":"B. Odenwald, H.G. D\u00f6rr, W. Bonfig, H. Schmidt, R. Fingerhut, M. Wildner, U. Nennstiel-Ratzel, Classic Congenital Adrenal Hyperplasia due to 21-Hydroxylase-Deficiency: 13 Years of Neonatal Screening and Follow-up in Bavaria. Klin. Padiatr. 227, 278\u2013283 (2015)","journal-title":"Klin. Padiatr"},{"key":"4759_CR59","doi-asserted-by":"publisher","first-page":"3172","DOI":"10.1210\/jc.2018-02468","volume":"104","author":"N Pode-Shakked","year":"2019","unstructured":"N. Pode-Shakked, A. Blau, B. Pode-Shakked, D. Tiosano, N. Weintrob, O. Eyal, A. Zung, F. Levy-Khademi, Y. Tenenbaum-Rakover, D. Zangen et al. Combined Gestational Age- and Birth Weight-Adjusted Cutoffs for Newborn Screening of Congenital Adrenal Hyperplasia. J. Clin. Endocrinol. Metab. 104, 3172\u20133180 (2019)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4759_CR60","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3390\/ijns9010009","volume":"9","author":"J Tippabathani","year":"2023","unstructured":"J. Tippabathani, V. Seenappa, A. Murugan, N.M. Phani, M.H. Hampe, G. Appaswamy, P. Sadashiv Gambhir, Neonatal Screening for Congenital Adrenal Hyperplasia in Indian Newborns with Reflex Genetic Analysis of 21-Hydroxylase Deficiency. Int. J. Neonatal Screen. 9, 9 (2023)","journal-title":"Int. J. Neonatal Screen."},{"key":"4759_CR61","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1159\/000535405","volume":"97","author":"R Saroufim","year":"2024","unstructured":"R. Saroufim, T.D. Nebesio, E.A. Eugster, Characteristics of Patients with Classic Congenital Adrenal Hyperplasia Missed on the Newborn Screen. Horm. Res. Paediatr. 97, 470\u2013476 (2024)","journal-title":"Horm. Res. Paediatr."},{"key":"4759_CR62","doi-asserted-by":"publisher","first-page":"e1194","DOI":"10.1210\/clinem\/dgae297","volume":"110","author":"K Sarafoglou","year":"2025","unstructured":"K. Sarafoglou, A. Gaviglio, C. Wolf, C.P. Lorentz, A. Lteif, J. Kyllo, G. Radloff, Z. Detwiler, C.D. Cuthbert, J.S. Hodges et al. Can Incorporating Molecular Testing Improve the Accuracy of Newborn Screening for Congenital Adrenal Hyperplasia? J. Clin. Endocrinol. Metab. 110, e1194\u2013e1203 (2025)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4759_CR63","doi-asserted-by":"publisher","first-page":"50","DOI":"10.3390\/ijns9030050","volume":"9","author":"B McCann-Crosby","year":"2023","unstructured":"B. McCann-Crosby, M.C. Liang, M.E. Geffner, C.M. Koppin, N.R. Fraga, V.R. Sutton, L.P. Karaviti, G. Bhullar, M.S. Kim, Differences in Hyperandrogenism Related to Early Detection of Non-Classical Congenital Adrenal Hyperplasia on Second Newborn Screen. Int. J. Neonatal Screen. 9, 50 (2023)","journal-title":"Int. J. Neonatal Screen."},{"issue":"Suppl 1","key":"4759_CR64","first-page":"3","volume":"17","author":"S Odaba\u015f\u0131 G\u00fcne\u015f","year":"2025","unstructured":"S. Odaba\u015f\u0131 G\u00fcne\u015f, H.N. Peltek Kendirci, E. \u00dcnal, A.D. Bulu\u015f, \u0130. D\u00fcndar, Z. \u015e\u0131klar, Clinical, Biochemical and Molecular Characteristics of Congenital Adrenal Hyperplasia Due to 21-hydroxylase Deficiency. J. Clin. Res. Pediatr. Endocrinol. 17(Suppl 1), 3\u201311 (2025)","journal-title":"J. Clin. Res. Pediatr. Endocrinol."},{"key":"4759_CR65","doi-asserted-by":"publisher","first-page":"2713","DOI":"10.1007\/s40618-025-02669-3","volume":"48","author":"F Baronio","year":"2025","unstructured":"F. Baronio, E. Abrigo, S. Azzolini, P. Cavarzere, C. Cereda, De L. Sanctis, S.L.C. Meroni, J. Munarin, F. Righetti, G. Russo et al. Newborn screening for congenital adrenal hyperplasia due to 21 hydroxylase deficiency: the Italian experience 2006\u20132019. J. Endocrinol. Invest. 48, 2713\u20132720 (2025)","journal-title":"J. Endocrinol. Invest."},{"issue":"Supplement1","key":"4759_CR66","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1210\/clinem\/dgae535","volume":"110","author":"M Yang","year":"2025","unstructured":"M. Yang, P.C. White, Genetics and Pathophysiology of Classic Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency. J. Clin. Endocrinol. Metab. 110(Supplement1), S1\u2013S12 (2025)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4759_CR67","doi-asserted-by":"publisher","first-page":"659492","DOI":"10.3389\/fped.2021.659492","volume":"9","author":"MC de Miranda","year":"2021","unstructured":"de M.C. Miranda, L.B.P. Haddad, E. Trindade, A. Cassenote, G.Y. Hayashi, D. Damiani, F.C. Costa, G. Madureira, de B.B. Mendonca, T.A.S.S. Bachega, The Cost-Effectiveness of Congenital Adrenal Hyperplasia Newborn Screening in Brazil: A Comparison Between Screened and Unscreened Cohorts. Front. Pediatr. 9, 659492 (2021)","journal-title":"Front. Pediatr."},{"key":"4759_CR68","doi-asserted-by":"publisher","first-page":"116","DOI":"10.3390\/ijns11040116","volume":"11","author":"X Jia","year":"2025","unstructured":"X. Jia, T. Xie, X. Jiang, F. Tang, M. Tan, Q. Chen, S. Liu, Y. Huang, L. Tao, Neonatal Screening for Congenital Adrenal Hyperplasia in Guangzhou: 7 Years of Experience. Int. J. Neonatal Screen. 11, 116 (2025)","journal-title":"Int. J. Neonatal Screen."},{"key":"4759_CR69","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1093\/ejendo\/lvaf208","volume":"193","author":"C Sow","year":"2025","unstructured":"C. Sow, T. Nguyen-Khoa, C. Moreau, J. Fiet, G. Bachelot, B. Ribault, O. Chaussenery, L. Al Zarga, A. Desmons, F. Brioude et al. FIRENDO Group. Advances in congenital adrenal hyperplasia newborn screening: 11-ketotestosterone and 21-deoxycortisone as additional discriminatory biomarkers. Eur. J. Endocrinol. 193, 677\u2013686 (2025)","journal-title":"Eur. J. Endocrinol."},{"key":"4759_CR70","first-page":"488","volume":"17","author":"T G\u00fcran","year":"2025","unstructured":"T. G\u00fcran, E. Y\u00fcr\u00fcker, A. An\u0131k, M. Atar, E. \u00c7amtosun, E. Eviz, M. \u0130sakoca, E. Mengen, B. G\u00fcrp\u0131nar Tosun, \u0130. Turan et al. The First-Year Outcomes of the Nationwide Neonatal CAH Screening in T\u00fcrkiye: High Rate of False Positives for 21-Hydroxylase Deficiency and a Higher Detection Rate of Non-Classical Cases. J. Clin. Res. Pediatr. Endocrinol. 17, 488\u2013493 (2025)","journal-title":"J. Clin. Res. Pediatr. Endocrinol."},{"key":"4759_CR71","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.jped.2025.03.003","volume":"101","author":"KPD Gameleira","year":"2025","unstructured":"K.P.D. Gameleira, J.V. Thomas, de V.G.B. Ara\u00fajo, C.V. Bolognani, S.E.S. Fernandes, F.F. Amorim, Cutoff levels for newborn screening of 21-OH deficiency in a Brazilian metropolitan area. J. Pediatr. (Rio J). 101, 561\u2013568 (2025)","journal-title":"J. Pediatr. (Rio J)"},{"key":"4759_CR72","doi-asserted-by":"crossref","unstructured":"e M.R. Hora, E. Thorstensen, N.L. Heather, B. Albert, D. Webster, P.L. Hofman, (2025) Expanded Steroid Profiling Identifies Novel Newborn Screening Markers for Congenital Adrenal Hyperplasia. J. Clin. Endocrinol. Metab. dgaf402 (2025)","DOI":"10.1210\/clinem\/dgaf402"},{"key":"4759_CR73","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1373\/clinchem.2003.027193","volume":"50","author":"JM Lacey","year":"2004","unstructured":"J.M. Lacey, C.Z. Minutti, M.J. Magera, Improved specificity of newborn screening for congenital adrenal hyperplasia by second-tier steroid profiling using tandem mass spectrometry. Clin. Chem. 50, 621\u2013625 (2004)","journal-title":"Clin. Chem."},{"key":"4759_CR74","doi-asserted-by":"publisher","first-page":"2581","DOI":"10.1210\/jc.2006-2890","volume":"92","author":"N Janzen","year":"2007","unstructured":"N. Janzen, S. Sander, M. Terhardt, Newborn screening for congenital adrenal hyperplasia: additional steroid profile using LC-MS\/MS reduces false-positive rates. J. Clin. Endocrinol. Metab. 92, 2581\u20132589 (2007)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4759_CR75","doi-asserted-by":"crossref","unstructured":"S.E. Lawrence, J. Marcadier, S. Auger, E. Bariciak, P. Chakraborty, A. Chambers, S. Eagle, M. Kowalski, A. Marr, N. McIntosh et al. (2025) Improved Performance of Newborn Screening for Congenital Adrenal Hyperplasia Using 21-deoxycortisol Measurement. J. Endocr. Soc. 10, bvaf157 (2025)","DOI":"10.1210\/jendso\/bvaf157"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-026-04759-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-026-04759-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-026-04759-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T23:02:46Z","timestamp":1790636566000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-026-04759-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,28]]},"references-count":75,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4759"],"URL":"https:\/\/doi.org\/10.1007\/s12020-026-04759-5","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,28]]},"assertion":[{"value":"18 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All Authors have nothing to declare.","order":1,"name":"Ethics","label":"Conflict of interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"311"}}